MS prevalence in New Zealand,an ethnically and latitudinally diverse country

Abstract

Background: The prevalence of multiple sclerosis (MS) is not uniform, with a latitudinal gradient of prevalence present in most studies. Understanding the drivers of this gradient may allow a better understanding of the environmental factors involved in MS pathogenesis.

Method: The New Zealand national MS prevalence study (NZMSPS) is a cross-sectional study of people with definite MS (DMS) (McDonald criteria 2005) resident in New Zealand on census night, 7 March 2006, utilizing multiple sources of notification. Capture—recapture analysis (CRA) was used to estimate missing cases.

Results: Of 2917 people with DMS identified, the crude prevalence was 72.4 per 100,000 population, and 73.1 per 100,000 when age-standardized to the European population. CRA estimated that 96.7% of cases were identified. A latitudinal gradient was seen with MS prevalence increasing three-fold from the North (35°S) to the South (48°S). The gradient was non-uniform; females with relapsing—remitting/secondary-progressive (RRMS/SPMS) disease have a gradient 11 times greater than males with primary-progressive MS (p < 1 × 10^-7). DMS was significantly less common among those of Māori ethnicity.

Conclusions: This study confirms the presence of a robust latitudinal gradient of MS prevalence in New Zealand. This gradient is largely driven by European females with the RRMS/SPMS phenotype. These results indicate that the environmental factors that underlie the latitudinal gradient act differentially by gender, ethnicity and MS phenotype. A better understanding of these factors may allow more targeted MS therapies aimed at modifiable environmental triggers at the population level.

Keywords

ethnicity gender ratio latitude multiple sclerosis prevalence

Get full access to this article

View all access options for this article.

References

Kurtzke JF MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl 1995; 161: 23-33.

Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-139.

Ascherio A. and Munger KL Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007; 61: 504-513.

Ascherio A. and Munger KL Environmental risk factors for multiple sclerosis. Part I: the role of infection . Ann Neurol 2007; 61: 288-299.

Ebers GC Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-277.

Sadovnick AD , Ebers GC , Dyment DA and Risch NJ Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728-1730.

McLeod JG , Hammond SR and Hallpike JF Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust 1994; 160: 117-122.

Kurtzke JF , Beebe GW and Norman Jr JE Epidemiology of multiple sclerosis in US veterans: 1. Race, sex, and geographic distribution. Neurology 1979; 29: 1228-1235.

Vukusic S. , Van Bockstael V. , Gosselin S. and Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers . J Neurol NeuroFsurg Psychiatry 2007; 78: 707-709.

10.

Skegg DC , Corwin PA , Craven RS , Malloch JA and Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987; 50: 134-139.

11.

Pugliatti M. , Sotgiu S. , Solinas G. , Castiglia P. and Rosati G. Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory. Neurol Sci 2001; 22: 163-165.

12.

Melcon MO , Gold L. , Carra A. , et al. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler 2008; 14: 656-662.

13.

Zivadinov R. , Iona L. , Monti-Bragadin L. , et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 2003; 22: 65-74.

14.

Alonso A. and Hernan MA Temporal trends in the incidence of multiple sclerosis: a systematic review . Neurology 2008; 71: 129-135.

15.

Van der Mei IA , Ponsonby AL , Blizzard L. and Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20: 168-174.

16.

Van der Mei IA , Ponsonby AL , Dwyer T. , et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003; 327: 316.

17.

Munger KL , Levin LI , Hollis BW , Howard NS and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296(23): 2832-2838.

18.

Haahr S. , Plesner AM , Vestergaard BF and Hollsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand 2004; 109: 270-275.

19.

Polman CH , Reingold SC , Edan G. , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005; 58: 840-846.

20.

Statistics New Zealand. ‘Profile of New Zealander Responses, Ethnicity Question: 2006 Census’ , http://www.stats.govt.nz (consulted January 2009).

21.

International Working Group for Disease Monitoring and Forecasting. Capture-recapture and multiple-record systems estimation I: history and theoretical development. Am J Epidemiol 1995; 142: 1047-1058.

22.

Forbes RB and Swingler RJ Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology. Am J Epidemiol 1999; 149: 1016-1024.

23.

Murphy M. , Quinn S. , Young J. , Parkin P. and Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 2008; 71: 1889-1895.

24.

Hook EB and Regal RR Recommendations for presentation and evaluation of capture-recapture estimates in epidemiology. J Clin Epidemiol 1999; 52: 917-926. discussion 929-933.

25.

Hook EB and Regal RR Validity of methods for model selection, weighting for model uncertainty, and small sample adjustment in capture-recapture estimation. Am J Epidemiol 1997; 145: 1138-1144.

26.

Orton SM , Herrera BM , Yee IM , et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study . Lancet Neurol 2006; 5: 932-936.

27.

Wallin MT , Page WF and Kurtzke JF Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis. Brain 2000 ; 123: 1677-1687.

28.

Ascherio A. and Munger K. Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 2008; 28: 17-28.

29.

Orton SM , Ramagopalan SV , Brocklebank DM , et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry 2010; 81: 31-36.